Business ❯Pharmaceutical Industry
Corporate Governance Moderna Pfizer COVID-19 Vaccines Moderna Inc. mRNA Technology Market Reactions Market Impact Novavax BioNTech
Full licensure of Moderna’s Spikevax for at-risk children underscores federal policy narrowing pediatric COVID-19 vaccination during ongoing legal challenges.